Delivery Order SPE2DB20D3103-SPE2DB24FP4G2

Award Date 7/5/24
Potential Completion Date 7/8/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies. The $12,558.00 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 6, 2025, with a completion date of March 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,467.95 firm fixed-price delivery order is for the supply of 4567624162 EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical devices. The contract has an ultimate completion date of March 20, 2025 and was awarded on March 19, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,129.01 firm fixed-price delivery order is for the supply of Epinephrine 0.3 mg auto-injectors, with a completion date of August 9, 2024. This contract is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which covers a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of 4,566,077,688 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA) under a firm fixed price delivery order. The contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and has been awarded this $3,301.26 contract with a completion date of October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,952.76 delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distribution company, on August 26, 2024, with a completion date of August 27, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,364.96 firm fixed-price delivery order is for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, with a period of performance through January 29, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as...
This federal contract award, valued at $1,226.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566164660 epinephrine 0.3 mg auto-injectors, with a completion date of October 22, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies. The award, valued at $3,712.80, was made by the Defense Logistics Agency (DLA), a defense agency, on December 4, 2024, with a completion date of December 5, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program and is part of a larger Indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Epinephrine 0.3 mg auto-inject devices. The $1,794.36 firm fixed price contract was awarded on July 12, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of July 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $5,949.60 for the supply of Epinephrine 0.3 mg auto-injectors. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 25, 2024. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a key...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP4G2
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical devices. The $1,495.30 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 5, 2024 with a completion date of July 8, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive federal contract awards demonstrate its role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 2/27/25, 10:17 AM